Lupin spurts on receiving EIR from US FDA for Goa facility

08 Jul 2016 Evaluate

Lupin is currently trading at Rs. 1673.35, up by 16.05 points or 0.97% from its previous closing of Rs 1657.30 on the BSE.

The scrip opened at Rs. 1700.00 and has touched a high and low of Rs. 1710.00 and Rs. 1652.25 respectively. So far 143639 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2127.00 on 06-Oct-2015 and a 52 week low of Rs. 1294.05 on 29-Mar-2016.

Last one week high and low of the scrip stood at Rs. 1695.95 and Rs. 1542.60 respectively. The current market cap of the company is Rs. 76963.53 crore.

The promoters holding in the company stood at 46.52%, while Institutions and Non-Institutions held 42.27% and 11.22% respectively.

Pharma Major Lupin has received notification that the inspection carried out by the US FDA in July 2015 at its Goa facility is now closed and the agency has issued an Establishment Inspection Reports (EIR). However, the responses from the March 2016 US FDA inspection and updates thereafter are still under review by the agency.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally. The Company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.

Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×